Kassberg Thomas Richard has filed 19 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 143789 shares of Passage BIO, Inc. ($PASG) on May 28, 2025.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 | Passage BIO, Inc. | $PASG | Kassberg Thomas Richard | Not found | A | Director Stock Option (right to buy) | 143789 | $0.00 | 143,789.0000 | 62,109,991 | 9999.99% | 0.23% |
| March 3, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | S | Common Stock | 6028 | $42.10 | 265,238.0000 | 90,538,118 | 2.22% | 0.01% |
| March 3, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | F | Common Stock | 508 | $42.92 | 264,730.0000 | 90,538,118 | 0.19% | 0.00% |
| March 1, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | A | Common Stock | 18443 | $0.00 | 271,266.0000 | 90,538,118 | 7.29% | 0.02% |
| Sept. 30, 2024 | Passage BIO, Inc. | $PASG | Kassberg Thomas Richard | Not found | A | Employee Stock Option (right to buy) | 174139 | $0.00 | 174,139.0000 | 3,142,537 | 9999.99% | 5.54% |
| March 11, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | S | Common Stock | 11509 | $49.93 | 252,823.0000 | 73,543,862 | 4.35% | 0.02% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | F | Common Stock | 274 | $53.69 | 265,343.0000 | 73,543,862 | 0.10% | 0.00% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | A | Common Stock | 17800 | $0.00 | 264,660.0000 | 73,543,862 | 7.21% | 0.02% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | A | Stock Option (Right to Buy) | 31400 | $0.00 | 31,400.0000 | 73,543,862 | 9999.99% | 0.04% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | S | Common Stock | 1011 | $53.76 | 264,332.0000 | 73,543,862 | 0.38% | 0.00% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | A | Common Stock | 957 | $0.00 | 265,617.0000 | 73,543,862 | 0.36% | 0.00% |
| Oct. 23, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | M | Common Stock | 39878 | $6.86 | 286,738.0000 | 69,914,225 | 16.15% | 0.06% |
| Oct. 23, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | S | Common Stock | 39878 | $32.78 | 246,860.0000 | 69,914,225 | 13.91% | 0.06% |
| Oct. 23, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | M | Stock Option (Right to Buy) | 39878 | $0.00 | 0.0000 | 69,914,225 | 100.00% | 0.06% |
| March 1, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | A | Common Stock | 2663 | $0.00 | 230,222.0000 | 69,914,225 | 1.17% | 0.00% |
| March 1, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | A | Common Stock | 22000 | $0.00 | 252,222.0000 | 69,914,225 | 9.56% | 0.03% |
| March 1, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | S | Common Stock | 1968 | $45.27 | 250,254.0000 | 69,914,225 | 0.78% | 0.00% |
| March 1, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | D | Common Stock | 3394 | $45.65 | 246,860.0000 | 69,914,225 | 1.36% | 0.00% |
| March 1, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Kassberg Thomas Richard | CBO & EVP | A | Stock Option (Right to Buy) | 39400 | $0.00 | 39,400.0000 | 69,914,225 | 9999.99% | 0.06% |